Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
40
NCT06463873
Study of OmniGraft in Simultaneous Pancreas Kidney Recipients
Phase: N/A
Role: Collaborator
Start: Jul 1, 2024
Completion: Feb 11, 2025